These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1621088)

  • 1. Do antidepressants promote tumors?
    Marx J
    Science; 1992 Jul; 257(5066):22-3. PubMed ID: 1621088
    [No Abstract]   [Full Text] [Related]  

  • 2. Global transcriptomic analysis of zebrafish in response to embryonic exposure to three antidepressants, amitriptyline, fluoxetine and mianserin.
    Wu M; Liu S; Hu L; Qu H; Pan C; Lei P; Shen Y; Yang M
    Aquat Toxicol; 2017 Nov; 192():274-283. PubMed ID: 28992598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses.
    Brandes LJ; Arron RJ; Bogdanovic RP; Tong J; Zaborniak CL; Hogg GR; Warrington RC; Fang W; LaBella FS
    Cancer Res; 1992 Jul; 52(13):3796-800. PubMed ID: 1617649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on fluoxetine in carcinogenicity.
    Hoffman WP; Long GG
    J Clin Psychopharmacol; 1996 Aug; 16(4):335-9. PubMed ID: 8835714
    [No Abstract]   [Full Text] [Related]  

  • 5. Tamoxifen for carcinoma of the male breast.
    Coffman BL
    Ann Intern Med; 1993 May; 118(9):749. PubMed ID: 8460869
    [No Abstract]   [Full Text] [Related]  

  • 6. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.
    Haque R; Shi J; Schottinger JE; Ahmed SA; Cheetham TC; Chung J; Avila C; Kleinman K; Habel LA; Fletcher SW; Kwan ML
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26631176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpreting the Delaney Clause in the 21st century.
    Picut CA; Parker GA
    Toxicol Pathol; 1992; 20(4):617-27, discussion 628-9. PubMed ID: 1308627
    [No Abstract]   [Full Text] [Related]  

  • 9. Tamoxifen prevention claim will not be allowed in USA.
    Ault A
    Lancet; 1998 Sep; 352(9131):883. PubMed ID: 9742990
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinogenicity studies of fluoxetine hydrochloride in rats and mice.
    Bendele RA; Adams ER; Hoffman WP; Gries CL; Morton DM
    Cancer Res; 1992 Dec; 52(24):6931-5. PubMed ID: 1458482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer prevention trials 'can re-start'.
    Gavaghan H
    Nature; 1994 Jun; 369(6481):515. PubMed ID: 8202147
    [No Abstract]   [Full Text] [Related]  

  • 12. National Surgical Adjuvant Breast and Bowel Project breast cancer prevention trial: a reflective commentary.
    Fisher B
    J Clin Oncol; 1999 May; 17(5):1632-9. PubMed ID: 10334553
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitrites: FDA beats a surprising retreat.
    Smith RJ
    Science; 1980 Sep; 209(4461):1100-1. PubMed ID: 7403871
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinogenesis bioassay results from the National Toxicology Program.
    Huff J
    Environ Health Perspect; 1982 Nov; 45():185-98. PubMed ID: 7140693
    [No Abstract]   [Full Text] [Related]  

  • 15. The maximum tolerated dose for inhalation bioassays: toxicity vs overload.
    Morrow PE; Haseman JK; Hobbs CH; Driscoll KE; Vu V; Oberdörster G
    Fundam Appl Toxicol; 1996 Feb; 29(2):155-67. PubMed ID: 8742311
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antidepressants and tamoxifen: an unrecognized interaction].
    Moulis M; Khouri C; Mallaret M
    Therapie; 2014; 69(2):178-9. PubMed ID: 24926638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1990 Sep; 264(10):1239. PubMed ID: 2388369
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.
    Jordan VC; Morrow M
    J Natl Cancer Inst; 2003 May; 95(9):683-4; author reply 684-5. PubMed ID: 12734320
    [No Abstract]   [Full Text] [Related]  

  • 19. The ED01 study: introduction, objectives, and experimental design.
    Cairns T
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):1-7. PubMed ID: 7365374
    [No Abstract]   [Full Text] [Related]  

  • 20. CYP2D6 pharmacogenomics of tamoxifen treatment.
    ; ;
    Technol Eval Cent Assess Program Exec Summ; 2014 Jan; 28(8):1-4. PubMed ID: 24730084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.